Furthermore, the serum TNF-α, IFN-γ, IL-1β, IL-6, and IL17 were significantly increased in the colitic mice, and hMSCs treatment could reduce these inflammatory cytokines, suggesting that hMSCs alleviated the inflammatory responses in colitis mice (Figure S7). Here, IL17A is linked to colitis.